Jizzo R. Bosdriesz
Research Subjects
Research Interests
Jizzo R. Bosdriesz has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Liza Coyer
Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands
2 shared publications - Maarten Franciscus Schim van der Loeff
Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands
2 shared publications Tjalling Leenstra
Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam) , Amsterdam
2 shared publicationsAa Matser
Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam, Netherlands
1 shared publicationAmy A Matser
Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam) , Amsterdam
1 shared publicationAmy A. Matser
Affiliations Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 8 July 2025
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 35 (5) , 1044-1049
The influence of case factors and system factors on the timeliness of testing and contact tracing for COVID-19 in The Netherlands
Source and contact tracing (SCT) is essential to control the transmission of SARS-CoV-2, and the timeliness of SCT is crucial. As little is known about its real-world effectiveness, we investigated the timeliness of SCT in the Netherlands and its determinants. We used routine COVID-19 SCT data from all individuals who tested positive for SARS-CoV-2 at nine Dutch public health services between 1 June 2020 and 28 February 2021 (N = 384 591). We calculated median time intervals between SCT stages. We used multilevel logistic regression to study associations between case factors and system factors, and total SCT delay (symptom onset to SCT initiation >3 days), patient delay (symptom onset to making test appointment >1 day), and response delay (making test appointment to SCT initiation >2 days). The median total SCT interval time was 3 days (interquartile range 2–5). Older age and being a migrant had higher odds of delay; working in health care or education had lower odds of delay. A higher caseload and a scaled-down SCT had higher odds of delay. For age and country of birth, stronger associations with patient delay, and weaker associations with response delay were found. Although SCT during the COVID-19 pandemic might have had merits in prompting people to isolate or quarantine before the availability of a vaccine, the observed interval times indicate that SCT was not fast enough to have a large effect on interrupting transmission chains. Although promising, the added value of digital SCT tools remains uncertain.
- 8 July 2025
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 35 (5) , 1044-1049
Open AccessThe influence of case factors and system factors on the timeliness of testing and contact tracing for COVID-19 in The Netherlands
Source and contact tracing (SCT) is essential to control the transmission of SARS-CoV-2, and the timeliness of SCT is crucial. As little is known about its real-world effectiveness, we investigated the timeliness of SCT in the Netherlands and its determinants. We used routine COVID-19 SCT data from all individuals who tested positive for SARS-CoV-2 at nine Dutch public health services between 1 June 2020 and 28 February 2021 (N = 384 591). We calculated median time intervals between SCT stages. We used multilevel logistic regression to study associations between case factors and system factors, and total SCT delay (symptom onset to SCT initiation >3 days), patient delay (symptom onset to making test appointment >1 day), and response delay (making test appointment to SCT initiation >2 days). The median total SCT interval time was 3 days (interquartile range 2–5). Older age and being a migrant had higher odds of delay; working in health care or education had lower odds of delay. A higher caseload and a scaled-down SCT had higher odds of delay. For age and country of birth, stronger associations with patient delay, and weaker associations with response delay were found. Although SCT during the COVID-19 pandemic might have had merits in prompting people to isolate or quarantine before the availability of a vaccine, the observed interval times indicate that SCT was not fast enough to have a large effect on interrupting transmission chains. Although promising, the added value of digital SCT tools remains uncertain.
- Open Access
- 25 October 2022
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 32 (Supplement)
The timeliness of COVID-19 testing and tracing in eight public health regions in the Netherlands
Background: Testing and Contact Tracing (TCT) was a core strategy in the fight against the spread of SARS-CoV-2. However, little is known about the real-world effectiveness of TCT for COVID-19. Because time is an important conditional factor, we aim to study timeliness of TCT in the Netherlands, and its determinants. Methods: We used routine COVID-19 TCT registry data from all individuals who tested positive for SARS-CoV-2 at 8 Dutch regional public health services from 1-6-2020 to 28-2-2021 (N = 338,066). We calculated median time intervals of TCT stages. Factors associated with the time between test result and completion of TCT, categorised as ≤ 3 days and >3 days, were assessed using logistic regression adjusting for region, testing site, and laboratory. Potential determinants were: gender, age, country of birth, number of close contacts, working in health-care or education, TCT manpower, and the Oxford Covid-19 Government Response Tracker (OxCGRT). Results: The median time from symptom onset to TCT completion was 6 days (IQR:3-10). Median times between TCT stages were 1 day (IQR:0-3) for symptom onset to test request, 1 day, (IQR:0-1) for test request to sample collection, 1 day, (IQR:1-1) for sample collection to test result, and 2 days (IQR:1-5) for test result to TCT completion. In 31.7% of tests, time between test result and TCT completion was >3 days. This delay was associated with being older (65+), whereas being younger (0-14), a higher OxCGRT, scaling down TCT, and a higher number of TCT employees were associated with a shorter interval. Conclusions: Over fifty percent of interval times from symptom onset to TCT completion exceeded the median SARS-CoV-2 incubation period of 5 days. There seems to be little room for improvement on the side of the index case, but there are some implications for logistics such as increasing TCT manpower, and better integration of digital systems. Key messages:
- 25 October 2022
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 32 (Supplement)
Open AccessThe timeliness of COVID-19 testing and tracing in eight public health regions in the Netherlands
Background: Testing and Contact Tracing (TCT) was a core strategy in the fight against the spread of SARS-CoV-2. However, little is known about the real-world effectiveness of TCT for COVID-19. Because time is an important conditional factor, we aim to study timeliness of TCT in the Netherlands, and its determinants. Methods: We used routine COVID-19 TCT registry data from all individuals who tested positive for SARS-CoV-2 at 8 Dutch regional public health services from 1-6-2020 to 28-2-2021 (N = 338,066). We calculated median time intervals of TCT stages. Factors associated with the time between test result and completion of TCT, categorised as ≤ 3 days and >3 days, were assessed using logistic regression adjusting for region, testing site, and laboratory. Potential determinants were: gender, age, country of birth, number of close contacts, working in health-care or education, TCT manpower, and the Oxford Covid-19 Government Response Tracker (OxCGRT). Results: The median time from symptom onset to TCT completion was 6 days (IQR:3-10). Median times between TCT stages were 1 day (IQR:0-3) for symptom onset to test request, 1 day, (IQR:0-1) for test request to sample collection, 1 day, (IQR:1-1) for sample collection to test result, and 2 days (IQR:1-5) for test result to TCT completion. In 31.7% of tests, time between test result and TCT completion was >3 days. This delay was associated with being older (65+), whereas being younger (0-14), a higher OxCGRT, scaling down TCT, and a higher number of TCT employees were associated with a shorter interval. Conclusions: Over fifty percent of interval times from symptom onset to TCT completion exceeded the median SARS-CoV-2 incubation period of 5 days. There seems to be little room for improvement on the side of the index case, but there are some implications for logistics such as increasing TCT manpower, and better integration of digital systems. Key messages:
- Open Access
- 24 August 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10 (8) , e31099
Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study
Background: Worldwide, efforts are being made to stop the COVID-19 pandemic caused by SARS-CoV-2. Contact tracing and quarantining are key in limiting SARS-CoV-2 transmission. Mathematical models have shown that the time between infection, isolation of cases, and quarantining of contacts are the most important components that determine whether the pandemic can be controlled. Mobile contact-tracing apps could accelerate the tracing and quarantining of contacts, including anonymous contacts. However, real-world observational data on the uptake and determinants of contact-tracing apps are limited. Objective: The aim of this paper is to assess the use of a national Dutch contact-tracing app among notified cases diagnosed with SARS-CoV-2 infection and investigate which characteristics are associated with the use of the app. Methods: Due to privacy regulations, data from the app could not be used. Instead, we used anonymized SARS-CoV-2 routine contact-tracing data collected between October 28, 2020, and February 26, 2021, in the region of Amsterdam, the Netherlands. Complete case logistic regression analysis was performed to identify which factors (age, gender, country of birth, municipality, number of close contacts, and employment in either health care or education) were associated with using the app. Age and number of close contacts were modelled as B-splines due to their nonlinear relationship. Results: Of 29,766 SARS-CoV-2 positive cases, 4824 (16.2%) reported app use. Median age of cases was 41 (IQR 29-55) years, and 46.7% (n=13,898) were male. In multivariable analysis, males (adjusted odds ratio [AOR] 1.11, 95% CI 1.04-1.18) and residents of municipalities surrounding Amsterdam were more likely to use the app (Aalsmeer AOR 1.34, 95% CI 1.13-1.58; Ouder-Amstel AOR 1.96, 95% CI 1.54-2.50), while people born outside the Netherlands, particularly those born in non-Western countries (AOR 0.33, 95% CI 0.30-0.36), were less likely to use the app. Odds of app use increased with age until the age of 58 years and decreased sharply thereafter (P<.001). Odds of app use increased with number of contacts, peaked at 8 contacts, and then decreased (P<.001). Individuals working in day care, home care, and elderly nursing homes were less likely to use the app. Conclusions: Contact-tracing app use among people with confirmed SARS-CoV-2 infection was low in the region of Amsterdam. This diminishes the potential impact of the app by hampering the ability to warn contacts. Use was particularly low among older people, people born outside the Netherlands, and people with many contacts. Use of the app was also relatively low compared to those from some other European countries, some of which had additional features beyond contact tracing, making them potentially more appealing. For the Dutch contact-tracing app to have an impact, uptake needs to be higher; therefore, investing more into promotional efforts and additional features could be considered.
- 24 August 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10 (8) , e31099
Open AccessFactors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study
Background: Worldwide, efforts are being made to stop the COVID-19 pandemic caused by SARS-CoV-2. Contact tracing and quarantining are key in limiting SARS-CoV-2 transmission. Mathematical models have shown that the time between infection, isolation of cases, and quarantining of contacts are the most important components that determine whether the pandemic can be controlled. Mobile contact-tracing apps could accelerate the tracing and quarantining of contacts, including anonymous contacts. However, real-world observational data on the uptake and determinants of contact-tracing apps are limited. Objective: The aim of this paper is to assess the use of a national Dutch contact-tracing app among notified cases diagnosed with SARS-CoV-2 infection and investigate which characteristics are associated with the use of the app. Methods: Due to privacy regulations, data from the app could not be used. Instead, we used anonymized SARS-CoV-2 routine contact-tracing data collected between October 28, 2020, and February 26, 2021, in the region of Amsterdam, the Netherlands. Complete case logistic regression analysis was performed to identify which factors (age, gender, country of birth, municipality, number of close contacts, and employment in either health care or education) were associated with using the app. Age and number of close contacts were modelled as B-splines due to their nonlinear relationship. Results: Of 29,766 SARS-CoV-2 positive cases, 4824 (16.2%) reported app use. Median age of cases was 41 (IQR 29-55) years, and 46.7% (n=13,898) were male. In multivariable analysis, males (adjusted odds ratio [AOR] 1.11, 95% CI 1.04-1.18) and residents of municipalities surrounding Amsterdam were more likely to use the app (Aalsmeer AOR 1.34, 95% CI 1.13-1.58; Ouder-Amstel AOR 1.96, 95% CI 1.54-2.50), while people born outside the Netherlands, particularly those born in non-Western countries (AOR 0.33, 95% CI 0.30-0.36), were less likely to use the app. Odds of app use increased with age until the age of 58 years and decreased sharply thereafter (P<.001). Odds of app use increased with number of contacts, peaked at 8 contacts, and then decreased (P<.001). Individuals working in day care, home care, and elderly nursing homes were less likely to use the app. Conclusions: Contact-tracing app use among people with confirmed SARS-CoV-2 infection was low in the region of Amsterdam. This diminishes the potential impact of the app by hampering the ability to warn contacts. Use was particularly low among older people, people born outside the Netherlands, and people with many contacts. Use of the app was also relatively low compared to those from some other European countries, some of which had additional features beyond contact tracing, making them potentially more appealing. For the Dutch contact-tracing app to have an impact, uptake needs to be higher; therefore, investing more into promotional efforts and additional features could be considered.
- Open Access
- 28 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0262287
Self-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands
Introduction: Most COVID-19 symptoms are non-specific and also common in other respiratory infections. We aimed to assess which symptoms are most predictive of a positive test for SARS-CoV-2 in symptomatic people of the general population who were tested. Methods: We used anonymised data of all SARS-CoV-2 test results from the Public Health Service of Amsterdam from June 1,2020 through August 31, 2021. Symptoms were self-reported at time of requesting a test. Multivariable logistic regression models with generalized estimating equations were used to identify predictors of a positive test. Included symptoms were: cough, fever, loss of smell or taste, muscle ache, runny nose, shortness of breath, and throat ache; adjustments were made for age and gender, and stratification by month. Results: Overall, 12.0% of 773,680 tests in 432,213 unique individuals were positive. All symptoms were significantly associated with a positive test result, the strongest positive associations were: cough (aOR = 1.78, 95%CI = 1.75–1.80), fever (aOR = 2.11, 95%CI = 2.07–2.14), loss of smell or taste (aOR = 2.55, 95%CI = 2.50–2.61), and muscle ache (aOR = 2.38, 95%CI = 2.34–2.43). The adjusted odds ratios for loss of smell or taste slightly declined over time, while that for cough increased. Conclusion: Cough, fever, loss of smell or taste, and muscle ache appear to be most strongly associated with a positive SARS-CoV-2 test in symptomatic people of the general population who were tested.
- 28 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0262287
Open AccessSelf-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands
Introduction: Most COVID-19 symptoms are non-specific and also common in other respiratory infections. We aimed to assess which symptoms are most predictive of a positive test for SARS-CoV-2 in symptomatic people of the general population who were tested. Methods: We used anonymised data of all SARS-CoV-2 test results from the Public Health Service of Amsterdam from June 1,2020 through August 31, 2021. Symptoms were self-reported at time of requesting a test. Multivariable logistic regression models with generalized estimating equations were used to identify predictors of a positive test. Included symptoms were: cough, fever, loss of smell or taste, muscle ache, runny nose, shortness of breath, and throat ache; adjustments were made for age and gender, and stratification by month. Results: Overall, 12.0% of 773,680 tests in 432,213 unique individuals were positive. All symptoms were significantly associated with a positive test result, the strongest positive associations were: cough (aOR = 1.78, 95%CI = 1.75–1.80), fever (aOR = 2.11, 95%CI = 2.07–2.14), loss of smell or taste (aOR = 2.55, 95%CI = 2.50–2.61), and muscle ache (aOR = 2.38, 95%CI = 2.34–2.43). The adjusted odds ratios for loss of smell or taste slightly declined over time, while that for cough increased. Conclusion: Cough, fever, loss of smell or taste, and muscle ache appear to be most strongly associated with a positive SARS-CoV-2 test in symptomatic people of the general population who were tested.
- Open Access
- 5 October 2020
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 25 (3) , 71-76
The association of coronary artery calcium score with glomerular filtration rate and the influence of sex, age, blood pressure, and cholesterol
The association of coronary artery calcium score with glomerular filtration rate and the influence of sex, age, blood pressure, and cholesterol
- 5 October 2020
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 25 (3) , 71-76
Open AccessThe association of coronary artery calcium score with glomerular filtration rate and the influence of sex, age, blood pressure, and cholesterol
The association of coronary artery calcium score with glomerular filtration rate and the influence of sex, age, blood pressure, and cholesterol
- Open Access
- 15 June 2020
- Published by Wiley in Nephrology
- Vol. 25 (10) , 737-743
Evidence‐based medicine—When observational studies are better than randomized controlled trials
In evidence‐based medicine, clinical research questions may be addressed by different study designs. This article describes when randomized controlled trials (RCT) are needed and when observational studies are more suitable. According to the Centre for Evidence‐Based Medicine, study designs can be divided into analytic and non‐analytic (descriptive) study designs. Analytic studies aim to quantify the association of an intervention (eg, treatment) or a naturally occurring exposure with an outcome. They can be subdivided into experimental (ie, RCT) and observational studies. The RCT is the best study design to evaluate the intended effect of an intervention, because the randomization procedure breaks the link between the allocation of the intervention and patient prognosis. If the randomization of the intervention or exposure is not possible, one needs to depend on observational analytic studies, but these studies usually suffer from bias and confounding. If the study focuses on unintended effects of interventions (ie, effects of an intervention that are not intended or foreseen), observational analytic studies are the most suitable study designs, provided that there is no link between the allocation of the intervention and the unintended effect. Furthermore, non‐analytic studies (ie, descriptive studies) also rely on observational study designs. In summary, RCTs and observational study designs are inherently different, and depending on the study aim, they each have their own strengths and weaknesses.
- 15 June 2020
- Published by Wiley in Nephrology
- Vol. 25 (10) , 737-743
Open AccessEvidence‐based medicine—When observational studies are better than randomized controlled trials
In evidence‐based medicine, clinical research questions may be addressed by different study designs. This article describes when randomized controlled trials (RCT) are needed and when observational studies are more suitable. According to the Centre for Evidence‐Based Medicine, study designs can be divided into analytic and non‐analytic (descriptive) study designs. Analytic studies aim to quantify the association of an intervention (eg, treatment) or a naturally occurring exposure with an outcome. They can be subdivided into experimental (ie, RCT) and observational studies. The RCT is the best study design to evaluate the intended effect of an intervention, because the randomization procedure breaks the link between the allocation of the intervention and patient prognosis. If the randomization of the intervention or exposure is not possible, one needs to depend on observational analytic studies, but these studies usually suffer from bias and confounding. If the study focuses on unintended effects of interventions (ie, effects of an intervention that are not intended or foreseen), observational analytic studies are the most suitable study designs, provided that there is no link between the allocation of the intervention and the unintended effect. Furthermore, non‐analytic studies (ie, descriptive studies) also rely on observational study designs. In summary, RCTs and observational study designs are inherently different, and depending on the study aim, they each have their own strengths and weaknesses.
- Open Access
Retiring from smoking: Reply to Kleykamp (2019)
Open AccessRetiring from smoking: Reply to Kleykamp (2019)
- Open Access
- 2 August 2019
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 5 (August) , 27
Did the introduction of pictorial health warnings increase information seeking for smoking cessation?: Time-series analysis of Google Trends data in six countries
Pictorial health warnings (PHW) can influence smoking cessation rates and precursors thereof. However, both the magnitude and duration of their impact, in national populations, remain uncertain because of limitations of the available data. In this study we used Google Trends data from six European countries to evaluate whether the implementation of PHW was followed by a short-term increase in online searches on smoking cessation. We applied an interrupted time-series design using ARIMA models. We used weekly or monthly data on the relative search volume (RSV) for search terms about smoking cessation. First, RSV trends were seasonally adjusted and adjusted for autocorrelation. Next, regression models were fitted that included terms for the potential effect of PHW in month 1, months 2-3, and months 4-6 after implementation. Our findings for France and the United Kingdom were partly in line with our initial expectations. In France, a 4% increase (95% CI: -2% - 11%) occurred in the first month after implementation, but not later. In the UK, a 3% increase (95% CI: 1% - 6%) in 'quit smoking' searches occurred in months 2-3. No increases were observed for any other periods for France, the UK, Ireland, Norway, Denmark or Switzerland. We found no consistent support that the implementation of PHW was associated with increased internet searches for smoking cessation. Further studies are needed to assess and understand the magnitude and duration of population-wide impacts of PHW.
- 2 August 2019
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 5 (August) , 27
Open AccessDid the introduction of pictorial health warnings increase information seeking for smoking cessation?: Time-series analysis of Google Trends data in six countries
Pictorial health warnings (PHW) can influence smoking cessation rates and precursors thereof. However, both the magnitude and duration of their impact, in national populations, remain uncertain because of limitations of the available data. In this study we used Google Trends data from six European countries to evaluate whether the implementation of PHW was followed by a short-term increase in online searches on smoking cessation. We applied an interrupted time-series design using ARIMA models. We used weekly or monthly data on the relative search volume (RSV) for search terms about smoking cessation. First, RSV trends were seasonally adjusted and adjusted for autocorrelation. Next, regression models were fitted that included terms for the potential effect of PHW in month 1, months 2-3, and months 4-6 after implementation. Our findings for France and the United Kingdom were partly in line with our initial expectations. In France, a 4% increase (95% CI: -2% - 11%) occurred in the first month after implementation, but not later. In the UK, a 3% increase (95% CI: 1% - 6%) in 'quit smoking' searches occurred in months 2-3. No increases were observed for any other periods for France, the UK, Ireland, Norway, Denmark or Switzerland. We found no consistent support that the implementation of PHW was associated with increased internet searches for smoking cessation. Further studies are needed to assess and understand the magnitude and duration of population-wide impacts of PHW.